Medra
AI-powered Robotics for Drug Discovery
8 open rolesAI-powered Robotics for Drug DiscoverySan Francisco, United States29 employees$63M raisedEst. 2021
Lux Capital
Menlo Ventures
Human Capital
Neo
NFDG
Catalio Capital Management
About Medra
- Medra AI develops an autonomous scientific experimentation platform that combines robotics with artificial intelligence to run and refine laboratory protocols.
- They are pioneering the next era of discovery by integrating AI algorithms with robotics execution to reinvent how new medicines are designed.
Medra is listed on Rocketlist with 8 active roles. The company is categorized as AI-powered Robotics for Drug Discovery in BioTech. Medra is at Series A stage, with a B2B business model, headquartered in San Francisco, United States. Medra was founded in 2021 and has 29 employees. Medra has raised $63M. Active roles are refreshed daily from public hiring sources.